Methocarbamol Injection recall
FDA recall D-0440-2024 · initiated Feb 15, 2024
Eugia US LLC recalled Methocarbamol Injection in Feb 2024 — an FDA Class I recall (D-0440-2024) because Presence of Particulate Matter.
Most serious — a reasonable probability that use will cause serious harm or death.
Why it was recalled
Presence of Particulate Matter
Something got into the product
A physical or chemical contaminant was found — glass or metal fragments, or a solvent that should not be there.
This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.
Is your product affected? Check the lot number
A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.
Quantity recalled: 1,552 10ml x 25/carton
Details
- Product
- Methocarbamol Injection, USP 1000mg/10mL, (100mg/mL), 10 mL Single-Dose Vial packed 25 vials per carton, Rx Only, Mfd. in India for: Eugia US LLC. E. Windsor, NJ 08520, NDC 55150-223-10
- Recalling company
- Eugia Pharma
- Classification
- Class I
- Status
- Ongoing
- Type
- Voluntary: Firm initiated
- Distribution
- Nationwide in the USA
- Initiated
- Feb 15, 2024
- FDA report date
- Apr 17, 2024
Frequently asked
- Was Methocarbamol Injection recalled?
- Eugia US LLC recalled Methocarbamol Injection in Feb 2024 — an FDA Class I recall (D-0440-2024) because Presence of Particulate Matter. Most serious — a reasonable probability that use will cause serious harm or death.
- Why was Methocarbamol Injection recalled?
- Per the FDA enforcement record, the reason for recall D-0440-2024 was: Presence of Particulate Matter
- Is a recalled Methocarbamol Injection dangerous to take?
- An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. Most serious — a reasonable probability that use will cause serious harm or death. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
- Which lots of Methocarbamol Injection are affected?
- Distributed: Nationwide in the USA. The recall covers these lots — Lot #: 3MC23011, Exp 11/30/2026. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0440-2024.